INS and diabetes mellitus: Our observation is in line with the those reporting a significantly decreased plasma glucose concentrations, only in patients with diabetes during sunitinib administration.23, 24 In addition, we observed at T1 higher insulin plasma levels (and HOMA‐IR) that may be associated with the lower glucose levels detected.